SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

About this episode

This episode discusses how SARS-CoV-2 mRNA vaccines may enhance the effectiveness of immune checkpoint blockade in treating tumours.

https://doi.org/10.1038/s41586-025-09655-y

People in this episode

Host: Raymond Ruff

Topics covered

• vaccines
• tumours
• immune response
• cancer therapy
• SARS-CoV-2

Keywords

• SARS-CoV-2
• mRNA vaccines
• tumours
• immune checkpoint blockade
• cancer

Mentioned in this episode

Organizations: SARS-CoV-2, mRNA vaccines, immune checkpoint blockade

Books & works: https://doi.org/10.1038/s41586-025-09655-y

More episodes of Science TLDR

• Episode 75: Trending — A 5.3-million-year-old deep-sea whale necropolis in the Diamantina Zone · June 12, 2026 · 19 min
• Episode 74: Discovery of TCR-like antibodies to the KRAS G12D neoantigen via in silico-in vitro workflow · June 9, 2026 · 12 min
• Episode 73: Trending — Work from Home and Disability Employment · June 5, 2026 · 23 min
• Episode 72: From free speech advocates to critics: The Trump administration’s new rhetoric promotes support for censorship among Trump voters · June 2, 2026 · 19 min
• Episode 71: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial · June 1, 2026 · 22 min
• Episode 70: Language Modeling Materializes a World Model of Protein Biology · May 27, 2026 · 20 min